Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers

Cerebrovascular Diseases

Volumn 19, Issue 4, 2005, Pages 214-219

  Caplain, H ^a,b  

^a Aster Cephac   (France)

^b NONE   (France)

Author keywords

Aspirin; Collagen; Platelet aggregation

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; ASASANTINE LP; CLOPIDOGREL; COLLAGEN; DIPYRIDAMOLE; THROMBYL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; DRUG RELEASE; DRUG SAFETY; HUMAN; MALE; MARKETING; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ADULT; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; COLLAGEN; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DIPYRIDAMOLE; DRUG THERAPY, COMBINATION; HUMANS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 17844384256     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083885     Document Type: Article

References (29)

1. Nenci GG: Unifying concept of arterial vascular disease. Eur Heart J Suppl 1999;1(suppl A):A27-A30.
2. Schafer AI: Antiplatelet therapy. Am J Med 1996;101:199-209.
3. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-235.
4. Savi P, Pereillo JM, Uzabiaga MF, Combalbert J, Picard C, Maffrand JP, Pascal M, Herbert JM: Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost 2000;84:891-896.
5. Gresele P, Arnout J, Deckmyn H, Vermylen J: Mechanism of the antiplatelet action of dipyridamole in whole blood: Modulation of adenosine concentration and activity. Thromb Haemost 1986;55:12-18.
6. Saniabadi AR, Fisher TC, McLaren M, Belch JF, Forbes CD: Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man. Cardiovasc Res 1991;25:177-183.
7. Gresele P, Zoja C, Deckmyn H, Arnout J, Vermylen J, Verstraete M: Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemost 1983;50:852-856.
8. Bult H, Fret HR, Jordaens FH, Herman AG: Dipyridamole potentiates platelet inhibition by nitric oxide. Thromb Haemost 1991;66:343-349.
9. Eisert WG: Near-field amplification of anti-thrombotic effects of dipyridamole through vessel wall cells. Neurology 2001;57:S20-S23.
10. Husain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA: Aspirin improves endothelial dysfunction in atherosclerosis. Circulation 1998;97:716-720.
11. 3 integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo. Blood 2002;99:3978-3984.
12. Herbert JM: Effects of ADP-receptor antagonism beyond traditional inhibition of platelet aggregation. Expert Opin Investig Drugs 2004;13:457-460.
13. Makkar RR, Eigler NL, Kaul S, Frimerman A, Nakamura M, Shah PK, Forrester JS, Herbert JM, Litvack F: Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis. Eur Heart J 1998;19:1538-1546.
14. Harker LA, Marzec UM, Kelly AB, Chronos NRF, Sundell IB, Hanson SR, Herbert J-M: Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 1998;98:2461-2469.
15. Herbert J-M, Dol F, Bernat A, Falotico R, Lalé A, Savi P: The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost 1998;80:512-518.
16. Cadroy Y, Bossavy J-P, Thalamas C, Sagnard L, Sakariassen K, Boneu B: Early potent anti-thrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation 2000;101:2823-2828.
17. Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, Meyer BJ: Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: Enhanced inhibitory effects of combination therapy. J Am Coll Cardiol 2000;36:699-705.
18. Gresele P, Armout J, Deckmyn H, Vermylen J: Combining antiplatelet agents: Potentiation between aspirin and dipyridamole. Lancet 1985;1:937-938.
19. Müller TH, Su CAPF, Weisenberger H, Brickl R, Nehmiz G, Eisert WG: Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo. Br J Clin Pharmacol 1990;30:179-186.
20. Folts JD, Rowe GG: Dipyridamole alone or with low-dose aspirin neither inhibits thrombus formation in stenosed canine coronary arteries nor protects against renewal of thrombus formation by epinephrine. J Vasc Med Biol 1989;1:255-261.
21. Herbert JM, Frehel D, Vallee E, Kieffer G, Gouy D, Berger Y, Necciari J, Defreyn G, Maffrand JP: Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovasc Drug Rev 1993;11:180-198.
22. Born GVR, Cross J: The aggregation of blood platelets. J Physiol 1963;168:178-195.
23. Department of Health and Human Services, Food and Drug Administration: Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labelling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products. Fed Regist 1998;63:56802-56819 (Docket No. 77N-094A).
24. CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
25. Diener H, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
26. Serebruany VL, Malinin AI, Sane DC: Rapid platelet inhibition after a single capsule of Aggrenox®: Challenging a conventional full-dose aspirin antiplatelet advantage? Am J Hematol 2003;72:280-281.
27. Cadroy Y, Thalamas C, Sakariassen K, Boneu B: Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers. Thromb Res 2005; in press.
28. Weselcouch EO, Humphrey WR, Aiken JW: Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery. J Pharmacol Exp Ther 1987;240:37-43.
29. Eisert WG: Dipyridamole exhibits antithrombotic and anti-inflammatory activities. Dipyridamole amplifies the endogenous antithrombotic mechanisms of the vessel wall. Int J Clin Pract 2003;(suppl)136:23-28.